Latest news,
from ANeuroTech

ANeuroTech in the media

Documentary about Aneurotech
Interview with dutch television

The inception of ANeuroTech is the result of my +3 decades of experience in the clinical development of neuroscience blockbusters in collaboration with Big Pharma.

My target is to bring an effective treatment for people that continue to suffer from depression with associated subjective cognitive problems.

Dr. Erik Buntinx, Psychiatrist, Inventor & Founding CEO of ANeuroTech


The Status of ANT01 and ANeuroTech

23 February 2022
FDA GRANTED ANT01 PHASE IIIB STUDY PROGRAM IN PARTIAL RESPONSIVE DEPRESSION (PRD).

Read more

Scroll to Top